EcoDrugPlus

Mapk Interacting Serine/threonine Kinase 2

Ensembl ID : ENSPFOG00000015486
Gene Symbol: MKNK2
3 Cross references
208 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSPFOG00000017322
Gene Symbol: MDM2
3 Cross references
275 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSPFOG00000022265
Gene Symbol: MET
2 Cross references
164 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSPFOG00000014244
Gene Symbol: MLST8
3 Cross references
198 Possible Orthologues:

Nad(P)h Dehydrogenase, Quinone 1

Ensembl ID : ENSPFOG00000015593
Gene Symbol: NQO1
1 Cross references
180 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSPFOG00000016445
Gene Symbol: NPC1L1
2 Cross references
189 Possible Orthologues:

P2x Purinoceptor 3-Like

Ensembl ID : ENSPFOG00000009198
Gene Symbol: LOC103147529
3 Cross references
192 Possible Orthologues:

Ptk6 Protein Tyrosine Kinase 6b

Ensembl ID : ENSPFOG00000023379
Gene Symbol: PTK6B
1 Cross references
157 Possible Orthologues:

Pim-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSPFOG00000019499
Gene Symbol: PIM1
1 Cross references
246 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSPFOG00000010103
Gene Symbol: PIM3
1 Cross references
172 Possible Orthologues:

Rac-Beta Serine/threonine-Protein Kinase

Ensembl ID : ENSPFOG00000006803
Gene Symbol: LOC103145381
3 Cross references
210 Possible Orthologues:

Rac-Gamma Serine/threonine-Protein Kinase

Ensembl ID : ENSPFOG00000012618
Gene Symbol: LOC103137460
3 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).